RDVT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RDVT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Red Violet's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 25.45%.
Red Violet's EBITDA per Share for the three months ended in Sep. 2024 was $0.35.
The historical data trend for Red Violet's YoY EBITDA Growth can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Red Violet Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
YoY EBITDA Growth | Get a 7-Day Free Trial | -44.49 | 71.54 | 238.64 | 63.61 | 53.91 |
Red Violet Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
YoY EBITDA Growth | Get a 7-Day Free Trial | -2.14 | 1,442.86 | 84.05 | 67.24 | 25.45 |
YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.
Red Violet's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:
YoY EBITDA Growth (A: Dec. 2023 ) | |||||
= | (EBITDA per Share (A: Dec. 2023 ) | - | EBITDA per Share (A: Dec. 2022 )) | / | | EBITDA per Share (A: Dec. 2022 ) | |
= | (0.768 | - | 0.499) | / | | 0.499 | |
= | 53.91 % |
Red Violet's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:
YoY EBITDA Growth (Q: Sep. 2024 ) | |||||
= | (EBITDA per Share (Q: Sep. 2024 ) | - | EBITDA per Share (Q: Sep. 2023 )) | / | | EBITDA per Share (Q: Sep. 2023 )) | |
= | (0.345 | - | 0.275) | / | | 0.275 | |
= | 25.45 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Red Violet's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.
Peter Benz | director | 171 MADISON AVE., 17 FL.,, NEW YORK NY 10016 |
Jeffrey Alan Dell | officer: Chief Information Officer | C/O IDI, INC., 2650 NORTH MILITARY TRAIL, SUITE 300, BOCA RATON FL 33431 |
Derek Dubner | director, officer: Chief Executive Officer | 2650 N. MILITARY TRAIL, SUITE 300, BOCA RATON FL 33431 |
Daniel Maclachlan | officer: Chief Financial Officer | 2650 NORTH MILITARY TRAIL, SUITE 300, BOCA RATON FL 33431 |
James Patrick Reilly | officer: President | 2650 N. MILITARY TRAIL, SUITE 300, BOCA RATON FL 33431 |
Michael Brauser | 10 percent owner | 4400 BISCAYNE BLVD., SUITE 850, MIAMI FL 33137 |
Greater Miami Jewish Federation, Inc. | 10 percent owner | 4200 BISCAYNE BLVD., MIAMI FL 33137 |
Lisa M. Stanton | director | 17064 CROSSGATE DRIVE, JUPITER FL 33477 |
Frost Phillip Md Et Al | 10 percent owner | 4400 BISCAYNE BLVD, MIAMI FL 33137-3227 |
Frost Gamma Investments Trust | 10 percent owner | 4400 BISCAYNE BLVD, MIAMI FL 33137 |
Robert Swayman | director | 5022 NW 102 DRIVE, CORAL SPRINGS FL 33076 |
Ryan Schulke | 10 percent owner | C/O IDI, INC., 2650 NORTH MILITARY TRAIL, SUITE 300, BOCA RATON FL 33431 |
Steven D Rubin | director | OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137 |
Jinbo Wang | officer: Chief Accounting Officer, other: Principal Accounting Officer | C/O TIGER MEDIA, INC. ROOM 1705, 511 WEIHAI ROAD, JING AN DISTRICT, SHANGHAI F4 200041 |
From GuruFocus
By Marketwired • 08-08-2024
By Marketwired • 07-30-2024
By GuruFocus News • 11-26-2024
By Marketwired • 08-13-2024
By Marketwired • 06-03-2024
By Marketwired • 11-06-2024
By Marketwired • 12-03-2024
By GuruFocus Research • 08-08-2024
By GuruFocus News • 12-06-2024
By GuruFocus Research • 08-09-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.